Morgan-Stanley

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
34,641
Total Value
881484701630
Accession Number
0000895421-25-000381
Form Type
13F-HR
Manager Name
Morgan-Stanley
Data Enrichment
83% identified
28,652 identified5,989 unidentified

Holdings

34,641 positions • $881.5B total value
Manager:
Search and click to pin securities to the top
Page 297 of 405
88634T535
Shares:2.6K
Value:$47.5K
% of Portfolio:0.0% ($47.5K/$881.5B)
Inhibikase Therapeutics, Inc.
Shares:21.6K
Value:$47.4K
% of Portfolio:0.0% ($47.4K/$881.5B)
025072315
Shares:922
Value:$47.4K
% of Portfolio:0.0% ($47.4K/$881.5B)
87283Q701
Shares:952
Value:$47.3K
% of Portfolio:0.0% ($47.3K/$881.5B)
14161WAB1
Shares:—
Value:$47.2K
% of Portfolio:0.0% ($47.2K/$881.5B)
Envela Corp
Shares:7.6K
Value:$47.1K
% of Portfolio:0.0% ($47.1K/$881.5B)
Cohen & Steers Select Preferred & Income Fund, Inc.
Shares:2.4K
Value:$47.1K
% of Portfolio:0.0% ($47.1K/$881.5B)
025072687
Shares:1.0K
Value:$47.1K
% of Portfolio:0.0% ($47.1K/$881.5B)
HARVARD BIOSCIENCE INC
Shares:83.0K
Value:$47.0K
% of Portfolio:0.0% ($47.0K/$881.5B)
NeuroSense Therapeutics Ltd.
Shares:50.5K
Value:$47.0K
% of Portfolio:0.0% ($47.0K/$881.5B)
63008J702
Shares:13.6K
Value:$46.4K
% of Portfolio:0.0% ($46.4K/$881.5B)
KKR Income Opportunities Fund
Shares:3.8K
Value:$46.2K
% of Portfolio:0.0% ($46.2K/$881.5B)
42727R104
Shares:91.9K
Value:$46.1K
% of Portfolio:0.0% ($46.1K/$881.5B)
33740F680
Shares:1.2K
Value:$46.1K
% of Portfolio:0.0% ($46.1K/$881.5B)
TILLY'S, INC.
Shares:20.9K
Value:$46.0K
% of Portfolio:0.0% ($46.0K/$881.5B)
Acrivon Therapeutics, Inc.
Shares:22.7K
Value:$46.0K
% of Portfolio:0.0% ($46.0K/$881.5B)
53656F821
Shares:1.3K
Value:$45.9K
% of Portfolio:0.0% ($45.9K/$881.5B)
Hanover Bancorp, Inc. /NY
Shares:2.1K
Value:$45.8K
% of Portfolio:0.0% ($45.8K/$881.5B)
29975EAD1
Shares:—
Value:$45.8K
% of Portfolio:0.0% ($45.8K/$881.5B)
LEE ENTERPRISES, Inc
Shares:4.4K
Value:$45.7K
% of Portfolio:0.0% ($45.7K/$881.5B)